Newsletter | May 7, 2025

05.07.25 -- How To Reduce mRNA Production COGS

SPONSOR

Webinar: Turbulent Times: How to successfully control the upscaling of your LNP formulation with KNAUER’s Impingement Jet Mixing

KNAUER’s webinar on Lipid Nano Particles (LNPs) covers fundamentals, formulation challenges, and upscaling strategies. Topics include lipid composition, mixing techniques like IJM, and GMP compliance. Designed for professionals, it offers insights into efficient, scalable LNP production from lab to industrial scale. Click here to learn more.

FEATURED EDITORIAL

"Mirror, Mirror…": Reflections On Reducing mRNA Production COGS

Here, I outline three overarching words of wisdom I gleaned from Life Edit Therapeutics’ April Sena; Tune Therapeutics’ Tyler Goodwin; and University of Sheffield’s Adi on how the mRNA/RNA industry can better control production costs — particularly as it relates to raw material sourcing and usage.  

Navigating Tariffs: Implications & Strategies For Pharma Manufacturers

The U.S. tariffs on trading partners bring a whole new set of challenges, but there are tactics and strategies companies can deploy to help offset the cost and operational impacts. 

Analytical Limitations In Assessing Plasmid Quality for mRNA Production

There remain a lot of gaps in our understanding of plasmid quality, particularly for high-quality mRNA production (as opposed to viral vector production). In this segment of a recent Advancing RNA Live panel, speakers Adi Nair, Tyler Goodwin, and April Sena highlight their biggest questions around plasmid DNA quality, as well as the pros and cons of some of the analytical methods upon which we’re relying most heavily today to assess plasmid quality.

CRI's Response to NIH Cuts with Alicia Zhou, Ph.D.

In this episode of the Cell & Gene podcast, Host Erin Harris speaks with Alicia Zhou, Ph.D., CEO of the Cancer Research Institute (CRI), about CRI’s mission to advance cancer immunotherapy and the critical role of federal funding, particularly from the NIH, in supporting basic and translational cancer research.

INDUSTRY INSIGHTS

Fast And Efficient Extraction Of mRNA From IVT Mixtures

Here, a fast and efficient way to purify polyadenylated mRNA using affinity chromatography on the CIMmultus Oligo dT column is presented.

Quality Assurance In IVT RNA Vaccine Development Using Electrophoresis

Discover advanced solutions for IVT RNA synthesis, focusing on enhancing fidelity in throughput, innovative technologies, and methodologies to optimize your RNA research and development processes.

Digital Biomanufacturing, Now: From Digital Dreamer To Digital Doer

See how digital biomanufacturing is innovating drug production by exploring strategies for integrating digital technologies to enhance efficiency, reliability, and innovation in bioprocessing workflows.

Regulatory Frameworks For mRNA Therapeutics

The RNA therapeutics and vaccines market has grown rapidly, driven by siRNA and mRNA technologies. Learn how these advancements are being applied to cancer vaccines and innovative therapeutics.

Empowering A New Era Of Patient-Centric Medicines

Discover the challenges pharma companies are facing as they switch focus as well as the actions and technologies companies are implementing to help achieve a brighter future for patients.

Regulatory Compliance In Clinical Research

Understand the critical aspects of regulatory compliance, and gain insights into how you can safeguard participant rights and ensuring the integrity of clinical research.

How Automation Can Accelerate Clinical Research And Outbreak Response

AI-driven automation and organ-on-a-chip technology have the potential to accelerate research with enhanced assay efficiency, improving vaccine and therapeutic development for global health threats.

Structural Characterization Of RNA And Detection Of RNA-Ligand Binding

Delve into the intricacies of riboswitch behavior and ligand interactions and gain valuable insights into gene regulation and potential therapeutic targets.

CMC And Regulatory Considerations For CRISPR Therapies

Uncover the intricacies of Chemistry, Manufacturing, and Controls and Critical Quality Attributes, which play an important role in gene editing.

SPONSOR

Join Advancing RNA Live for a dynamic discussion on the latest regulatory guidances from global agencies and what they mean for mRNA vaccine and therapeutic development. Discover key challenges, actionable insights, and best practices to accelerate your programs—no matter your approach. Don’t miss this opportunity to gain expert-driven clarity. Registration is free thanks to the support of Roche CustomBiotech.